8.32
price up icon3.10%   0.25
after-market Dopo l'orario di chiusura: 8.34 0.02 +0.24%
loading

Kala Bio Inc Borsa (KALA) Ultime notizie

pulisher
07:04 AM

Technical analysis overview for KALA BIO Inc. stock2025 Breakouts & Breakdowns & Trade Opportunity Analysis Reports - Newser

07:04 AM
pulisher
04:19 AM

What’s next for KALA BIO Inc. stock priceGap Down & Long-Term Safe Investment Plans - Newser

04:19 AM
pulisher
02:14 AM

Using Python tools to backtest KALA BIO Inc. strategiesGold Moves & AI Forecast for Swing Trade Picks - Newser

02:14 AM
pulisher
09:20 AM

Can KALA BIO Inc. recover in the next quarterJuly 2025 Decliners & Consistent Growth Equity Picks - Newser

09:20 AM
pulisher
07:22 AM

How KALA BIO Inc. stock performs during market volatility2025 Trading Volume Trends & Daily Growth Stock Investment Tips - Newser

07:22 AM
pulisher
06:07 AM

Is KALA BIO Inc. a Top Dividend Stock to Watch in 2025Earnings Risk Summary & Weekly Watchlist for Consistent Profits - Newser

06:07 AM
pulisher
04:53 AM

Price momentum metrics for KALA BIO Inc. explainedQuarterly Profit Review & Weekly Breakout Stock Alerts - Newser

04:53 AM
pulisher
01:04 AM

KALA BIO Inc. Company’s Quarterly Earnings Growth: What the Numbers SayMarket Movers & AI Optimized Trading Strategy Guides - Newser

01:04 AM
pulisher
Aug 14, 2025

KALA BIO Inc. stock trend forecastCEO Change & Smart Money Movement Alerts - Newser

Aug 14, 2025
pulisher
Aug 14, 2025

Wall Street Analysts Believe KALA BIO (KALA) Could Rally 74.73%: Here's is How to Trade - MSN

Aug 14, 2025
pulisher
Aug 14, 2025

Institutional Tools Highlight Unusual Flow in KALA BIO Inc.Bear Alert & Low Risk Growth Stock Ideas - newsyoung.net

Aug 14, 2025
pulisher
Aug 14, 2025

KALA BIO Inc. Building a Base Near Support2025 Retail Activity & Proven Capital Preservation Tips - sundaytimes.kr

Aug 14, 2025
pulisher
Aug 13, 2025

Comparing KALA BIO Inc. in custom built stock radars2025 Risk Factors & Intraday High Probability Alerts - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

Statistical indicators supporting KALA BIO Inc.’s strengthNew Guidance & Safe Entry Point Alerts - Newser

Aug 13, 2025
pulisher
Aug 12, 2025

Is KALA BIO Inc. showing insider buyingROIC-Focused Investment List - thegnnews.com

Aug 12, 2025
pulisher
Aug 12, 2025

Why KALA BIO Inc. stock attracts strong analyst attentionMachine Learning Stock Movement Detector - Newser

Aug 12, 2025
pulisher
Aug 11, 2025

Using portfolio simulators with KALA BIO Inc. includedFree Swing Setup With Technical Confirmation - Newser

Aug 11, 2025
pulisher
Aug 11, 2025

What makes KALA BIO Inc. stock price move sharplyFree Risk Managed Intraday Trade Alerts - Newser

Aug 11, 2025
pulisher
Aug 11, 2025

Can volume confirm reversal in KALA BIO Inc.Free AI Screening for Swing Trade Picks - Newser

Aug 11, 2025
pulisher
Aug 10, 2025

Kala Bio Reports Q2 2025 Earnings: EPS -$1.82, Revenue Unavailable; Focus on Advancing KPI-012 for Rare Eye Diseases. - AInvest

Aug 10, 2025
pulisher
Aug 10, 2025

Trend analysis for KALA BIO Inc. this weekWeekly Trend Watch with Market Signals - Newser

Aug 10, 2025
pulisher
Aug 09, 2025

What drives KALA BIO Inc.’s stock priceStocks with 300% Upside - sisaissue.com

Aug 09, 2025
pulisher
Aug 09, 2025

KALA BIO: Q2 Earnings Snapshot - Greenwich Time

Aug 09, 2025
pulisher
Aug 09, 2025

KALA BIO (NASDAQ:KALA) Stock Rating Lowered by Wall Street Zen - Defense World

Aug 09, 2025
pulisher
Aug 08, 2025

Momentum divergence signals in KALA BIO Inc. chartShort-Term Profit Alert With Entry Forecast - Newser

Aug 08, 2025
pulisher
Aug 08, 2025

Kala Bio (KALA) Q2 Loss Widens 15% - AOL.com

Aug 08, 2025
pulisher
Aug 08, 2025

KALA BIO Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 08, 2025
pulisher
Aug 08, 2025

Kala Bio Q2 Loss Widens 15%, KPI-012 Enrollment Completed - AInvest

Aug 08, 2025
pulisher
Aug 08, 2025

Biotech's Long Game: Assessing KALA BIO's Q2 Loss in the Context of Strategic Innovation - AInvest

Aug 08, 2025
pulisher
Aug 08, 2025

Kala Bio (KALA) Q2 Loss Widens 15% - The Motley Fool

Aug 08, 2025
pulisher
Aug 08, 2025

KALA BIO, Inc. Completes Patient Enrollment in Phase 2b CHASE Trial for KPI-012 in Persistent Corneal Epithelial Defect, Reports Financial Results and Upcoming Milestones - Quiver Quantitative

Aug 08, 2025
pulisher
Aug 08, 2025

KALA BIO, Inc. SEC 10-Q Report - TradingView

Aug 08, 2025
pulisher
Aug 08, 2025

KALA BIO Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire

Aug 08, 2025
pulisher
Aug 08, 2025

KALA Bio Completes Phase 2b Trial Enrollment for Novel PCED Eye Treatment | KALA Stock News - Stock Titan

Aug 08, 2025
$36.35
price down icon 0.41%
$86.92
price up icon 0.88%
$26.69
price up icon 0.91%
$127.80
price up icon 0.04%
$113.52
price up icon 0.73%
biotechnology ONC
$321.36
price up icon 3.77%
Capitalizzazione:     |  Volume (24 ore):